DNA viruses pose a devastating risk to human life and the economy. Preventing viral diseases primarily by vaccination is of utmost importance. However, the emergence of new variants is a major challenge. To address this major health concern, a recent in vivo study has reported the efficacy of a compound called centanamycin (CM) to produce whole-virion, chemically attenuated, replication-defective live DNA viruses that can be used as potential vaccines .
The study found that immunization with CM-attenuated mouse cytomegalovirus (MCMV) demonstrated a robust immune response and decreased the viral load against challenges with live, wild-type MCMV. The major benefit offered by this vaccine is its safety, efficacy, and induction of a large antigen pool infecting host cells . Other advantages include sufficient memory T cell production, strong inhibition of virus replication, absence of…
